Bioptimus has rapidly established itself as a leader in AI for biology, securing $76 million in funding to build the first universal AI foundation model for biology. Their flagship H-Optimus model ranks #1 out of 22 foundation models for digital pathology, with the company on track to reach 1 million downloads across its foundation models. Approximately 100 scientific publications annually leverage Bioptimus models to advance research, demonstrating significant academic adoption and impact.
Training on an unprecedented 2 billion images and benefiting from data contributed by over 4,000 clinical practices, Bioptimus breaks down biological data silos to connect information from molecules to entire organisms. This comprehensive approach enables breakthrough discoveries in drug discovery, clinical trials, and patient treatment decisions. By transforming multiscale biological data into actionable insights, Bioptimus accelerates innovation in biomedicine and beyond, helping researchers and clinicians better understand complex biological systems.
